HALF YEARLY RESULTS
Sun Pharmaceutical Industries Ltd.
BSE
Apr 30
1830.20
+25.40 (+ 1.41%)
Volume
34570
Prev. Close
1804.80
Open Price
1809.70
Bid Price(Qty.)
0.00 (0)
Offer Pr.(Qty.)
0.00 (0)
NSE
Apr 30
1832.30
+26.80 (+ 1.48%)
Volume
2667314
Prev. Close
1805.50
Open Price
1810.00
Bid Price(Qty.)
0.00 (0)
Offer Pr.(Qty.)
0.00 (0)
You can view the
Halfyearly Results
for the last 5 years.
|
ISIN No
|
INE044A01036
|
Market Cap. ( ₹ in Cr. )
|
439630.15
|
P/BV
|
6.36
|
Book Value ( ₹ )
|
288.06
|
|
BSE Code
|
524715
|
52 Week High/Low ( ₹ )
|
1960/1377
|
FV/ML
|
1/1
|
P/E(X)
|
45.91
|
|
NSE Code
|
SUNPHARMAEQ
|
Book Closure
|
06/02/2025
|
EPS ( ₹ )
|
39.91
|
Div Yield (%)
|
0.74
|
(₹ in Crs.)
| Net Sales/Income from operations | 9625.78 | 10712.89 | 9562.28 | 10350.75 | 10218.17 |
| Other Operating Income | 0.00 | 0.00 | 0.00 | 243.22 | 0.00 |
| Total Income From Operations | 9625.78 | 10712.89 | 9562.28 | 10593.97 | 10218.17 |
| | | | | | |
| EXPENDITURE | | | | | |
| Consumption of Raw Materials | 2198.24 | 2177.51 | 2251.87 | 2438.62 | 2727.01 |
| Purchase of Traded Goods | 666.35 | 516.70 | 477.71 | 529.87 | 596.59 |
| Increase/Decrease in Stocks | -198.39 | 99.16 | 81.16 | -142.30 | -95.63 |
| Employees Cost | 1307.67 | 1166.10 | 1207.85 | 1055.29 | 1101.66 |
| Depreciation | 655.34 | 792.64 | 807.98 | 842.42 | 758.45 |
| Other Expenses | 3552.22 | 3500.89 | 3208.61 | 3352.46 | 2775.71 |
| Total Expenses | 8181.43 | 8253.00 | 8035.18 | 8076.36 | 7863.79 |
| | | | | | |
| P/L Before Other Inc. , Int., Excpt. Items & Tax | 1444.35 | 2459.89 | 1527.10 | 2517.61 | 2354.38 |
| Other Income | 169.04 | 195.68 | 270.08 | 188.33 | 90.70 |
| P/L Before Interest, Excpt. Items & Tax | 1613.39 | 2655.57 | 1797.18 | 2705.94 | 2445.08 |
| Interest | 459.83 | 432.51 | 351.57 | 292.34 | 179.84 |
| P/L Before Exceptional Items & Tax | 1153.56 | 2223.06 | 1445.61 | 2413.60 | 2265.24 |
| Exceptional Items | 0.00 | -69.81 | -149.21 | -2937.79 | 0.00 |
| P/L Before Tax | 1153.56 | 2153.25 | 1296.40 | -524.19 | 2265.24 |
| Tax | 52.45 | 564.34 | 27.13 | 9.90 | 40.43 |
| P/L After Tax from Ordinary Activities | 1101.11 | 1588.91 | 1269.27 | -534.09 | 2224.81 |
| Net Profit/Loss For the Period | 1101.11 | 1588.91 | 1269.27 | -534.09 | 2224.81 |
| | | | | | |
| Equity Share Capital | 239.93 | 239.93 | 239.93 | 239.93 | 239.93 |
| Reserves And Surplus | 0.00 | 23454.47 | 0.00 | 0.00 | 0.00 |
| EPS Before Extra Ordinary * | | | | | |
| Basic EPS (Rs.) | 4.60 | 6.62 | 5.30 | -2.23 | 9.30 |
| Diluted EPS (Rs.) | 4.60 | 6.62 | 5.30 | (2.23) | 9.30 |
| EPS After Extra Ordinary * | | | | | |
| Basic EPS (Rs.) | 4.60 | 6.62 | 5.30 | -2.23 | 9.30 |
| Diluted EPS (Rs.) | 4.60 | 0.00 | 5.30 | 0.00 | 9.30 |
| | | | | | |
| PBITOE Margin (%) | 15.00 | 22.96 | 15.97 | 23.76 | 23.04 |
| PBTE Margin (%) | 11.98 | 20.75 | 15.11 | 22.78 | 22.16 |
| PBT Margin (%) | 11.98 | 20.09 | 13.55 | -4.94 | 22.16 |
| PAT Margin (%) | 11.43 | 14.83 | 13.27 | -5.04 | 21.77 |